Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Binds antigen or epitope whose amino acid sequence is...
Reexamination Certificate
2011-06-14
2011-06-14
Szperka, Michael (Department: 1644)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Binds antigen or epitope whose amino acid sequence is...
C424S133100, C424S141100, C424S144100, C424S805000, C424S810000, C530S387300, C530S387900, C530S388100, C530S388250, C530S862000
Reexamination Certificate
active
07959917
ABSTRACT:
This invention relates to binding members, especially antibody molecules, for IgE. The binding members are useful for, inter alia, treatment of disorders mediated by IgE including allergies and asthma.
REFERENCES:
patent: 5693762 (1997-12-01), Queen et al.
patent: 5994511 (1999-11-01), Lowman et al.
patent: 6172213 (2001-01-01), Lowman et al.
patent: 2005/0169909 (2005-08-01), Singh et al.
patent: 8906138 (1989-07-01), None
patent: 9111456 (1991-08-01), None
patent: 9304173 (1993-03-01), None
patent: 9421676 (1994-09-01), None
patent: 9704807 (1997-02-01), None
patent: 9901556 (1999-01-01), None
patent: 200050460 (2000-08-01), None
patent: 2003030833 (2003-04-01), None
patent: 2004000217 (2003-12-01), None
patent: 2004070010 (2004-08-01), None
patent: 2004070011 (2004-08-01), None
patent: 2005075504 (2005-08-01), None
patent: 2008099188 (2008-08-01), None
Janeway et al., Immunobiology, 3rd edition, 1997, Garland Press, pp. 3:1 to 3:11.
William E. Paul, M.D. ed., Fundamental Immunology, 3d ed. 1993, p. 242.
Portolano et al., J Immunol. Feb. 1, 1993;150(3):880-7.
Rudikoff et al., Proc Natl Acad Sci U S A. Mar. 1982;79(6):1979-83.
Zheng et al., Biochem Biophys Res Commun. Oct. 31, 2008;375(4):619-22. Epub Aug. 24, 2008.
Barbas et al., Proc Natl Acad Sci U S A. Mar. 28, 1995;92(7):2529-33.
Clemens et al., Int Immunol. Dec. 1998;10(12):1931-42.
Wurzburg B A et al: “Structure of the human IgE-Fc Cepsilon3-Cepsilon4 reveals conformational flexibility in the antibody effector domains” Immunity, Cell Press, US, vol. 13, No. 3, Sep. 1, 2000, pp. 375-385, ISSN: 1074-7613.
Holt L J et al: “Domain antibodies: proteins for therapy” Trends in Biotechnology, Elsevier Publications, Cambridge, GB, vol. 21, No. 11, Nov. 1, 2003, pp. 484-490, ISSN: 0167-7799.
Davies J et al: “Affinity improvement of single antibody VH domains: residues in all three hypervariable regions affect antigen binding” Immunotechnology, Elsevier Science Publishers BV, NL, vol. 2, No. 3, Sep. 1, 1996, pp. 169-179, ISSN: 1380-2933.
Cochrane Duncan
Cohen Suzanne
Dobson Claire Louise
Eriksson Per-Olof
Monk Phillip David
MedImmune Limited
Szperka Michael
LandOfFree
Binding members for IgE molecules does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Binding members for IgE molecules, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Binding members for IgE molecules will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2691783